Navigo Proteins GmbH


Navigo Proteins GmbH




Sales & Marketing, KOL Advisory, Design of IND-enabling Studies, Regulatory Strategy, Target Product Profile, Market Assessment, Development Plan, Investor Pitch, Business Plan & Corporate Prospectus, IP Development




To provide target product profiles for a biotherapeutics platform, including competitive and SWOT analysis for select disease areas.

“Novateur ideally complements Navigo’s capacities to guarantee a seamless transition of early discovery into pre-clinical and clinical development based on a sound and focused business case. We are looking forward to continuing and expanding our partnership with Novateur.”

Dr. Henning Afflerbach
Managing Director, Navigo Proteins


Platforms often have infinite possibilities. How do you choose the best possible indication or products?

Navigo Proteins retained Novateur’s expert to evaluate its platform and advise on the best possible Target Product Profiles in the areas of Ophthalmology, Oncology and Metabolic Diseases. Within 8 weeks the Novateur team developed detailed competitive analysis of each space, and given the opportunities of target areas and strengths of Navigo’s platform provided several Target Product Profiles of “Concept Products” in oncology, ophthalmology and metabolic diseases.


Learn more about Navigo Proteins

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!